С.Наранчимэг
Loading...
Товч нэр
С.Наранчимэг
Бүтэн нэр
Содовсүрэн Наранчимэг
Латин нэр
Sodovsuren Naranchimeg
Эрдмийн цол
Профессор
Боловсролын зэрэг
Доктор (Ph.D)
Харьяалал
ORCID
Scopus Author ID
18 results
Now showing 1 - 10 of 18
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, - Some of the metrics are blocked by yourconsent settings
Item type:Publication, - Some of the metrics are blocked by yourconsent settings
Item type:Publication, - Some of the metrics are blocked by yourconsent settings
Item type:Publication, - Some of the metrics are blocked by yourconsent settings
Item type:Publication, - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Uncontrolled hypertension and non adherence to medical therapy in Ulaanbaatar, MongoliaObjectives: The purposes of this study were (1) to measure non-adherence to medical therapy in a representative sample of the hypertensive population in Mongolia; (2) to identify factors influencing non-adherence to anti-hypertensive medication; and (3) to compare non-adherence to medication in the uncontrolled and controlled hypertension groups. Methods: This descriptive study was a questionnaire-based cross-sectional analysis. A random sample of 735 hypertensive patients, aged 35-64 years was selected. Arterial hypertension was defined as uncontrolled if blood pressure ≥140/90 mmHg. Non-adherence to medication was assessed using the Morisky Medication Adherence Scale with a four-item questionnaire. Results: The study sample consisted of 265 men (36.1%) and 470 women (63.9%). The mean age of participants was 53.8 ± 8.7 years. Uncontrolled hypertension was detected in 84.7% of all hypertensive subjects. We wound 68.3% of hypertensive patient’s non-adherence to medical treatment. Significant factors influencing non-adherence to anti[1]hypertensive medication among the hypertensive population in Mongolia were younger age (35-44), low family income, not having a regular doctor for hypertension control, behavior of irregular medication intake and mono-therapy. Conclusion: Non-adherence to medical treatment was significantly more common in the uncontrolled hypertension group compared with controlled the hypertension group (79.3% vs. 7.1%, p<0.001). - Some of the metrics are blocked by yourconsent settings
Item type:Publication, - Some of the metrics are blocked by yourconsent settings
Item type:Publication, A2030 Non-adherence to medication and risk factors of non-compliance among Mongolian people with arterial hypertension(Ovid Technologies (Wolters Kluwer Health), 2018-10); ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, [PS 03-13] HYPERTENSION AWARENESS, TREATMENT AND CONTROL IN MONGOLIA(Ovid Technologies (Wolters Kluwer Health), 2016-09); ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Association between NT- pro BNP and Cardio-metabolic Risk Factors in Mongolians(2021-07-30); ; ;Ganbat Mijidsuren ;Ganchimeg UlziisaikhanObjective of the study was to evaluate the association of NT-pro BNP to cardio-metabolic risk factors, including the metabolic syndrome. Research method: This study was included 194 participant s aged from 35- to 64 years, who were health checkup examinee’s and had no clinical symptoms of heart failure. Cardio-metabolic risk factors were detected by clinical examinations and laboratory test. Metabolic syndrome was defined according to the International Diabetes Federation definition. NT-pro BNP determination was performed on an immunoassay analyzer (FIA8000, Getein Bio Medical Inc). The cut-off point for NT-pro BNP was 125pg/ml. We examined with multivariate linear regression of the relationship between NT-pro BNP and cardio-metabolic risk factors. A logistic regression analysis was also performed to assess the influence of cardio-metabolic risk factors and metabolic syndrome on NT- pro BNP values. Research results: A total of 194 participants included in the study of which, 75 (38.6%) were men and 119 (61.4%) were women. The mean age was 51.3±7.9 75 years. Thirty-two participant s (16.5%) showed elevated NT-pro BNP levels of ≥125 pg/ml. Sixty-one (31.4%) participants had metabolic syndrome. Multivariate linear regression analysis showed that age (β=0.140, P=0.049), systolic blood pressure (β=0.198, P=0.007) and diastolic blood pressure (β=0.174, P=0.018) were positively correlated with NT-pro BNP levels, while body mass index (β=-0.209, P=0.004) was negatively correlated with NT-pro BNP levels. Age (OR=1.07, P=0.011) and hypertension (OR=5.98, P=0.007) were the independent predictors of elevated NT-pro BNP levels. Conclusion: NT-pro BNP levels were significantly increased in participants with hypertension and metabolic syndrome and were lower in obesity.
